Company · CIK 0001850838
Omega Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-25-033500 · 157.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-027349 · 161.6 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-019359 · 169.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-014403 · 149.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-008477 · 153.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-004507 · 146.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-287201 · 154.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-272532 · 148.5 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-24-258595 · 7.9 MBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-24-127008 · 9.9 MBSEC(opens sec.gov)
Insiders
- AFEYAN NOUBARDirector, 10% Owner
- Artal Group S.A.10% Owner
- Artal International S.C.A.10% Owner
- BERRY DAVID ADirector
- BESHAR LUKE MDirector
- Boehm Rainer J.Director
- Certel KaanChief Business Officer
- Chan Barbara YChief Accounting Officer
- Flagship Pioneering Fund VII, L.P.10% Owner
- Flagship Pioneering, LLC10% Owner
Tickers
No tickers on record.
Addresses
business
140 FIRST STREET, SUITE 501
CAMBRIDGE, MA, 02141
mailing
140 FIRST STREET, SUITE 501
CAMBRIDGE, MA, 02141
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies